BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3176536)

  • 1. [Quantitative-kinetic aspects of granulocytic resistance to infection in hematologic systemic diseases with reference to antineoplastic chemotherapy].
    Sommer S
    Z Arztl Fortbild (Jena); 1988; 82(11):513-5. PubMed ID: 3176536
    [No Abstract]   [Full Text] [Related]  

  • 2. Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies.
    Zuckerman E; Zuckerman T; Douer D; Qian D; Levine AM
    Cancer; 1998 Sep; 83(6):1224-30. PubMed ID: 9740089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation.
    Baron F; Gothot A; Salmon JP; Hermanne JP; Pierard GE; Fillet G; Beguin Y
    Br J Haematol; 2000 Dec; 111(3):745-53. PubMed ID: 11122133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of cytostatic therapy in hemoblastoses on phagocytosis of neutrophilic granulocytes].
    Gottschalk U; Stobbe H
    Z Arztl Fortbild (Jena); 1986; 80(23):981-3. PubMed ID: 3472417
    [No Abstract]   [Full Text] [Related]  

  • 5. Fifth biannual report of the Cochrane Haematologic Malignancies Group--Focus on multiple myeloma.
    Naumann F; Weingart O; Kruse E; Schulz H; Bohlius J; Hülsewede H; Engert A;
    J Natl Cancer Inst; 2006 Aug; 98(16):E2. PubMed ID: 16912255
    [No Abstract]   [Full Text] [Related]  

  • 6. [Leukocytic changes under treatment with L-asparaginase].
    Kolarz G; Pietschmann H
    Wien Med Wochenschr; 1971 Mar; 121(11):196-9. PubMed ID: 4254383
    [No Abstract]   [Full Text] [Related]  

  • 7. Sodium and potassium excretion changes and bone marrow recovery after chemotherapy.
    Kiss I; Tomasek J
    Stem Cells; 1999; 17(4):233-4. PubMed ID: 10437987
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of chemotherapy on hematopoietic stem cells in peripheral blood].
    Nieto MJ; Cañizo C; Corral M; Almeida J; San Miguel J
    Sangre (Barc); 1996 Feb; 41(1):29-35. PubMed ID: 8779031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myelotoxicity due to cancer chemotherapy].
    Nakamura S; Yoshida T; Ohtake S; Itoh K; Kobayashi K; Nakanishi J; Matsuda T; Natori H; Egami K
    Nihon Gan Chiryo Gakkai Shi; 1986 Oct; 21(9):2196-205. PubMed ID: 3029252
    [No Abstract]   [Full Text] [Related]  

  • 10. [Second neoplasms in malignant hematologic disorders. Experience from 1978 to 1987].
    Cristoffanini A; Zapata C; León A; Salas P
    Rev Med Chil; 1990 May; 118(5):522-9. PubMed ID: 2293272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular status of individual CFU-GM colonies derived from chemotherapy-mobilised peripheral blood stem cells in chronic myeloid leukaemia.
    Broughton CM; Sherrington P; Pender NT; Clark RE
    Genes Chromosomes Cancer; 1997 Apr; 18(4):292-8. PubMed ID: 9087569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab associated to imatinib for coexisting therapy-related chronic myeloid leukaemia and relapsed non-Hodgkin lymphoma.
    Breccia M; Martelli M; Cannella L; Russo E; Finolezzi E; Stefanizzi C; Levi A; Frustaci A; Alimena G
    Leuk Res; 2008 Feb; 32(2):353-5. PubMed ID: 17825907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case report of chronic myelogenous leukemia in a patient with multiple myeloma and a review of the literature.
    Ragupathi L; Najfeld V; Chari A; Petersen B; Jagannath S; Mascarenhas J
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):175-9. PubMed ID: 23168212
    [No Abstract]   [Full Text] [Related]  

  • 14. Hematological malignancy and pregnancy: a single-institution experience of 21 cases.
    Dilek I; Topcu N; Demir C; Bay A; Uzun K; Gul A; Faik Oner A; Ugras S
    Clin Lab Haematol; 2006 Jun; 28(3):170-6. PubMed ID: 16706933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Personal experience on the chemotherapy of leukemias and hematosarcomas].
    Mathé G; Schneider M; Schwarzenberg L; Cattan A; Amiel JL; Schlumberger JR
    Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):245-54. PubMed ID: 4874537
    [No Abstract]   [Full Text] [Related]  

  • 16. Leukemia.
    McKenna SJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Feb; 89(2):137-9. PubMed ID: 10673646
    [No Abstract]   [Full Text] [Related]  

  • 17. [Protocols for the treatment of leukemia and lymphoma: toward escalation or toward reduction of degree?].
    Mathé G; Misset JL; Machover D; Schwarzenberg L; Timus M; Jasmin C; Ribaud P; Musset M
    Biomed Pharmacother; 1984; 38(1):13-32. PubMed ID: 6380605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic granulocytic leukemia in a dog.
    Fine DM; Tvedten HW
    J Am Vet Med Assoc; 1999 Jun; 214(12):1809-12, 1791. PubMed ID: 10382023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periodic morphologic, cytogenetic and clonality evaluation after autologous peripheral blood progenitor cell transplantation in patients with lymphoproliferative malignancies.
    Laurenti L; Chiusolo P; Garzia MG; Zini G; Sorà F; Piccirillo N; Piccioni P; Zollino M; Leone G; Sica S
    Haematologica; 2002 Jan; 87(1):59-66. PubMed ID: 11801466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thymostimulin as an adjuvant to antineoplastic chemotherapy. Experience with patients with myeloma and lymphoma].
    Cánovas Fernández A; González de Zárate P; Alonso Alonso J; Aguirre Errasti C
    Rev Clin Esp; 1988 Nov; 183(7):340-3. PubMed ID: 3212263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.